Posted on 1/8/18
Trieza Therapeutics Names Jeno Gyuris, Ph.D., as Chief Scientific Officer
Trieza Therapeutics, Inc. today announced that Jeno Gyuris, Ph.D., has joined the company as Chief Scientific Officer.
Posted on 1/8/18
Potenza Therapeutics Unveils Pipeline of Immuno-Oncology Programs
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Potenza Therapeutics today provided insights into its portfolio of immuno-oncology therapies that turn on or off the signaling mechanisms that control a patients‘ own . . .
Posted on 1/8/18
Stanley Lapidus Joins Atlas Genetics Board of Directors
Atlas Genetics, a rapid, near-patient and point-of-care (POC) testing company, today announced that it has appointed Stanley Lapidus
Posted on 1/8/18
Miami VA Healthcare System Adds LiveData PeriOp Planner to Streamline Patient Access to Surgical Care
CAMBRIDGE, Mass.--(BUSINESS WIRE)--LiveData, Inc.today announced that the Miami Department of Veterans Affairs healthcare facility has addedLiveData PeriOp Planner™ to the medical center’s LiveData PeriOp Manager™ workflow . . .
Posted on 1/8/18
Audax Private Equity to Acquire Corsearch
Audax Private Equity announced that it has agreed to acquire Corsearch, a division of Wolters Kluwer
Posted on 1/8/18
Harbour BioMed Announces Multi-Year Transgenic Platform Licensing Agreement with BeiGene
SHANGHAI & ROTTERDAM, The Netherlands & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Harbour BioMed announced today that it has licensed its patented H2L2 transgenic mouse platform for generating fully human . . .
Posted on 1/8/18
Alnylam and Sanofi Enter into Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance
CAMBRIDGE, Mass. & PARIS--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, andSanofiannounced today a strategic restructuring of their RNAi therapeutics alliance to streamline . . .
Posted on 1/8/18
Alnylam Announces 2018 Corporate Goals
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc.(Nasdaq:ALNY), the leading RNAi therapeutics company, today announced its corporate goals for 2018. The goals focus on clinical and regulatory progress against . . .
Posted on 1/7/18
NKF Capital Markets Completes the Sale of Middlesex Marketplace in Burlington
NKF Capital Markets has successfully completed the sale of Middlesex Marketplace in Burlington, Massachusetts to a private real estate fund advised by Crow Holdings Capital Partners-Real . . .
Posted on 1/5/18
Management Matters: Honesty = Courage, Candor, & Tact(+ Timing)
Most people don’t start out wanting to lie, although I do think there are those who prefer not to tell the truth. I have noticed that . . .
Posted on 1/5/18
3 Reasons to Be Hopeful of a General Electric Stock Turnaround
Oh, how the mighty have fallen!The slide of General Electric (NYSE:GE) in 2017 was just painful to watch, even if you don't own any of its . . .
Posted on 1/5/18
iRobot Is Ready to Bring Smart Homes to the Next Level
If you thought your Roomba's only job was to clean your floors, iRobot (NASDAQ:IRBT) wants you to think again. On Wednesday, the company announced it will . . .
Posted on 1/5/18
BlueVenn Acquires LEAP Media Solutions
BlueVenn has today announced the purchase of LEAP Media Solutions (LEAP), a provider of customer analytics and marketing campaign services for the US media industry.
Posted on 1/5/18
EyeGate Promotes Sarah Romano to Chief Financial Officer
WALTHAM, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ:EYEG), a clinical-stage, specialty pharmaceutical company with two platform technologies for treating diseases and disorders . . .
Posted on 1/5/18
Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer
CAMBRIDGE, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for . . .
Posted on 1/5/18
BRIDGE Energy Group Appoints Dr. Ray Gogel to Board of Directors
BRIDGE Energy Group(BRIDGE) today announced that Dr. Ray Gogel has accepted the company’s offer to join its board of directors. As
Posted on 1/5/18
Micron Products Announces New $9,500,000 Credit Facility
FITCHBURG, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Micron Products, Inc., a wholly owned subsidiary of Micron Solutions, Inc. (NYSE American:MICR), entered into a new three-year . . .
Posted on 1/4/18
Harbour Group Acquires Thibaut from Champlain Capital Partners
Thibaut, Inc., a portfolio company of Champlain Capital Partners was acquired by Harbour Group. BB&T Capital Markets
Posted on 1/4/18
Spark Capital Joins $75M Funding for Wealthfront
Wealthfront announced a $75 million round of financing led by Tiger Global Management with participation from all existing venture capital investors, including Benchmark Capital, DAG Ventures, . . .
Posted on 1/4/18
Parthenon-backed Hanson McClain and Simply Money to Merge
Hanson McClain Advisors and Simply Money Advisors, two leading financial planning investment advisory firms
Posted on 1/4/18
Agent Capital Raises $52M for Maiden Venture Capital Fund
Agent Capital has raised $52 million for a maiden venture capital fund, according to a filing with the SEC.The Cambridge, Mass.,- based biotech fund has a . . .
Posted on 1/4/18
GPP Exits Autism Learning Partners
Great Point Partners is pleased to announce that it exited its investment in GPP I portfolio company, Autism Learning Partners. ALP is the leading provider of . . .
Posted on 1/4/18
RFE Invests in ThreeBridge
RFE Investment Partners is pleased to announce that it has completed a recapitalization of ThreeBridge Solutions, LLC, through which it has acquired a majority ownership interest . . .
Posted on 1/4/18
Concord Raises $10M Series A Led by CRV
SAN FRANCISCO--(BUSINESS WIRE)--Concord, a leading contract management platform, today announced the closing of $10 million Series A funding. The round was led by CRV (Charles River . . .
Posted on 1/4/18
Oak HC/FT Leads $30M Series C for NextCapital
NextCapital, the leader in enterprise digital advice, is pleased to announce the completion of its Series C Preferred Stock financing
Boston
